• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ciprofloxacin versus ceftazidime in skin and soft tissue infections.

作者信息

Thadepalli H, Mathai D, Chuah S K, Bansal M B

机构信息

Division of Infectious Diseases, Martin Luther King, Jr. General Hospital, Drew University School of Medicine and Science, Los Angeles, CA 90059.

出版信息

J Chemother. 1989 Feb;1(1):30-4. doi: 10.1080/1120009x.1989.11738860.

DOI:10.1080/1120009x.1989.11738860
PMID:2656929
Abstract

Intravenous ciprofloxacin therapy was evaluated in comparison with i.v. ceftazidime in the treatment of skin and soft tissue infections and were found to be comparable. Intravenous or peroral forms of ciprofloxacin may be used instead of intravenously given third generation cephalosporins or aminoglycosides in the treatment of even severe infections of the skin and soft tissue.

摘要

相似文献

1
Ciprofloxacin versus ceftazidime in skin and soft tissue infections.
J Chemother. 1989 Feb;1(1):30-4. doi: 10.1080/1120009x.1989.11738860.
2
Prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or soft-tissue infections.
Am J Med. 1989 Nov 30;87(5A):136S-137S. doi: 10.1016/0002-9343(89)90043-0.
3
Intravenous fleroxacin versus ceftazidime for lower respiratory tract and skin and soft-tissue infections.
Clin Ther. 1992 Jul-Aug;14(4):595-602.
4
Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure.
Am J Med. 1989 Nov 30;87(5A):132S-135S. doi: 10.1016/0002-9343(89)90042-9.
5
Intravenous/oral ciprofloxacin therapy versus intravenous ceftazidime therapy for selected bacterial infections.
Am J Med. 1989 Nov 30;87(5A):169S-175S. doi: 10.1016/0002-9343(89)90051-x.
6
Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infections.
Am J Med. 1989 Nov 30;87(5A):176S-180S. doi: 10.1016/0002-9343(89)90052-1.
7
Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections.
Am J Med. 1989 Nov 30;87(5A):160S-163S. doi: 10.1016/0002-9343(89)90049-1.
8
Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.
Am J Med. 1989 Nov 30;87(5A):164S-168S. doi: 10.1016/0002-9343(89)90050-8.
9
Efficacy and safety of intravenous ciprofloxacin in the treatment of serious infections. A comparison with ceftazidime.
Am J Med. 1989 Nov 30;87(5A):198S-201S. doi: 10.1016/0002-9343(89)90058-2.
10
Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections.
Am J Med. 1989 Nov 30;87(5A):116S-118S. doi: 10.1016/0002-9343(89)90037-5.